Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00480142
Status:
UNKNOWN
Last Update Posted:
2007-06-06
First Post:
2007-04-26
Brief Title:
Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy
Sponsor:
Kaplan Medical Center
Organization:
Kaplan Medical Center
Study Overview
Official Title:
Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy Prospective Double Blind Randomized Placebo-Controlled Study
Status:
UNKNOWN
Status Verified Date:
2007-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Prospective Double Blind RCT Controlled Release Oxycodone 10 mg On a 12 h Dosing Schedule Started With The Premedication Placebo Controlled StudyOn Post Operative Analgesia Management in Laparoscopic Cholecystectomy and Laparoscopic Bilateral Inguinal Hernia BIH
CRO is indicated for the management of moderate to severe pain when a continuousaround the clock analgesic is needed for an extended period of timeIts safety and efficacy in the first 12-24 hours post operative has not been established
CRO is indicated for the management of moderate to severe pain when a continuousaround the clock analgesic is needed for an extended period of timeIts safety and efficacy in the first 12-24 hours post operative has not been established
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None